IRONWOOD PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $51.3M | $40.8M | $-2.3M | $40.1M | $23.6M | $-37.4M | $2.3M | $3.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $457.0K | $443.0K | $460.0K | $475.0K | $467.0K | $479.0K | $485.0K | $507.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.2M | $3.7M | $3.8M | $3.6M | $4.5M | $5.3M | $4.6M | $8.3M |
| Net Cash from Operating Activities | $58.3M | $5.1M | $74.6M | $47.6M | $-15.1M | $20.0M | $15.2M | $9.9M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $-1.0K | $2.0K | $2.0K | $31.0K | $0 | $16.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $1.0K | $-2.0K | $-2.0K | $-31.0K | $0 | $-16.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $122.0K | $0 | $88.0K | $6.0K | $-14.9M | $-27.2M |
| Net Change in Cash | $-141.3M | $5.0M | $75.0M | $47.6M | $-15.6M | $19.9M | $348.0K | $-17.3M |
| Free Cash Flow | — | — | $74.6M | $47.6M | $-15.1M | $19.9M | $15.2M | $9.9M |